Born and raised in Ecuador, Rafael Bermeo moved to France in 2011 to attend the Lyon Superior School of Chemistry, Physics and Electronics (CPE Lyon), where he obtained his Bachelor, then his Chemical Engineering Diploma in 2018. During his diploma, Rafael spent one year as an exchange graduate student at Oregon State University (Corvallis, OR, USA), where he specialized in Organic Synthesis and Chemical Biology. In 2018, he started his PhD as a Marie Skłodowska-Curie fellow of the European network PhD4GlycoDrug. Enrolled at the Grenoble and Milan universities under Dr Annabelle Varrot and Prof. Anna Bernardi, he worked towards the design of inhibitors for the superlectin BC2L-C. He was recently granted a doctoral degree by both universities and will continue his career within the Novartis Innovation postdoctoral program (Basel, Switzerland). Rafael’s main interest revolves around using organic synthesis, medicinal chemistry and chemical biology to tackle current pathologies in new, efficient ways.